These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

563 related articles for article (PubMed ID: 13367602)

  • 1. A study of the relationship of concentrations of prothrombin, proconvertin, and proaccelerin to three methods for measuring prothrombin time.
    GONYEA LM; HJORT P; OWREN PA
    J Lab Clin Med; 1956 Oct; 48(4):624-33. PubMed ID: 13367602
    [No Abstract]   [Full Text] [Related]  

  • 2. [Analytical study on Quick test; determination of prothrombin, proconvertin, and proaccelerin].
    SOULIER JP; LARRIEU MJ
    Sang; 1952; 23(7):549-59. PubMed ID: 13004906
    [No Abstract]   [Full Text] [Related]  

  • 3. Prothrombin and proconvertin in the newborn and during the first year of life.
    DYGGVE H
    Acta Paediatr (Stockh); 1958 May; 47(3):251-9. PubMed ID: 13532682
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of phenylindanedione on the coagulation factors prothrombin, factor V and factor VII and the question of vitamin K resistance].
    PERLICK E
    Klin Wochenschr; 1953 Mar; 31(11-12):261-3. PubMed ID: 13070456
    [No Abstract]   [Full Text] [Related]  

  • 5. [Evaluation of liver function by determination of factor V, factor VII and prothrombin; effects of synkavit and vitamin K1].
    FORELL MM; KOLLER F
    Munch Med Wochenschr; 1953 Apr; 95(15):433-7. PubMed ID: 13072403
    [No Abstract]   [Full Text] [Related]  

  • 6. The influence of ACTH on prothrombin-proconvertin values in blood during treatment with dicumarol and phenylindanedione.
    HELLEM AJ; SOLEM JH
    Acta Med Scand; 1954; 150(5):389-93. PubMed ID: 13217736
    [No Abstract]   [Full Text] [Related]  

  • 7. The blood coagulation mechanism with especial reference to the prothrombin-proconvertin contents of plasma during long-term ACTH or cortisone therapy.
    FISCHER F; LUND E
    Acta Med Scand; 1954; 149(3):179-85. PubMed ID: 13180225
    [No Abstract]   [Full Text] [Related]  

  • 8. Control of anticoagulant therapy. A comparison of the thrombotest, the prothrombin-proconvertin method, and the prothrombin time.
    FICHERA C
    Acta Med Scand; 1962 Sep; 172():363-7. PubMed ID: 13945019
    [No Abstract]   [Full Text] [Related]  

  • 9. PROTHROMBIN LEVELS DURING THE FIRST YEAR OF LIFE. OBSERVATIONS FOLLOWED BY THE SYNTHETIC SUBSTRATE (TAME) ASSAY OF NORMAL FULL-TERM INFANTS.
    GLUECK HI; SUTHERLAND J; GLESER G
    Am J Dis Child; 1964 Jun; 107():612-7. PubMed ID: 14133821
    [No Abstract]   [Full Text] [Related]  

  • 10. Some biochemical and electrophoretic studies on purified prothrombin, factor VII (proconvertin) and factor X (Stuart).
    TISHKOFF GH; PECHET L; ALEXANDER B
    Blood; 1960 May; 15():778-90. PubMed ID: 13838500
    [No Abstract]   [Full Text] [Related]  

  • 11. [Changes in factors of the prothrombin complex (prothrombin, proconvertin, proaccelerin) in chronic hepatitis and cirrhosis].
    Stănescu M; Stroescu F
    Med Interna (Bucur); 1967 Apr; 19(4):417-23. PubMed ID: 6052153
    [No Abstract]   [Full Text] [Related]  

  • 12. Micromethod for quantitative determination of plasma prothrombin and proconvertin.
    DYGGVE H; LUND E
    Acta Med Scand; 1954; 150(3):207-14. PubMed ID: 13206681
    [No Abstract]   [Full Text] [Related]  

  • 13. Preparation of a human plasma fraction rich in prothrombin, proconvertin, Stuart factor, and PTC and a study of its activity and toxicity in rabbits and man.
    DIDISHEIM P; LOEB J; BLATRIX C; SOULIER JP
    J Lab Clin Med; 1959 Feb; 53(2):322-30. PubMed ID: 13621053
    [No Abstract]   [Full Text] [Related]  

  • 14. Control of dicumarol therapy by means of a micromethod for the quantitative determination of plasma prothrombin and proconvertin.
    LUND E; DYGGVE H
    Acta Med Scand; 1954; 150(4):271-5. PubMed ID: 13217722
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical studies on blood coagulation factors, prothrombin, factor V and factor VII liver diseases and their response to vitamin K1 and synka-vit].
    WITTE S; DIRNBERGER P
    Klin Wochenschr; 1953 Sep; 31(33-34):781-7. PubMed ID: 13097910
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies of prothrombin and proconvertin (SPCA); concentrations in plasma of patients with pernicious anemia in remission, treated with vitamin B12.
    VETNE G; AXELROD AR
    Am J Clin Pathol; 1954 Jul; 24(7):796-801. PubMed ID: 13171349
    [No Abstract]   [Full Text] [Related]  

  • 17. The effect of oral and intravenous administration of vitamins K on the prothrombin and proconvertin levels of cholecystnephrostomized dogs.
    FISHER LM; JAQUES LB; MILLAR GJ
    Can J Biochem Physiol; 1956 Sep; 34(5):1039-51. PubMed ID: 13364731
    [No Abstract]   [Full Text] [Related]  

  • 18. Blood coagulation in pregnancy: proconvertin and prothrombin, and the hypercoagulable state.
    ALEXANDER B; MEYERS L; KENNY J; GOLDSTEIN R; GUREWICH V; GRINSPOON L
    N Engl J Med; 1956 Feb; 254(8):358-63. PubMed ID: 13288790
    [No Abstract]   [Full Text] [Related]  

  • 19. [Methodological and clinical studies on the isolated determination of coagulation factor VII and prothrombin].
    WITTE S; DIRNBERGER P
    Dtsch Arch Klin Med; 1952; 199(5-6):492-501. PubMed ID: 13033518
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effect of nitrogen mustards on various factors of blood coagulation; recalcification time, prothrombin time, factor VII, factor V and fibrinogen].
    MASETTO I; BUTTO M
    Acta Med Patav; 1956; 16(1):81-94. PubMed ID: 13339128
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 29.